491 related articles for article (PubMed ID: 16932341)
21. Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis.
Martinelli S; Maffei R; Castelli I; Santachiara R; Zucchini P; Fontana M; Bonacorsi G; Leonardi G; Marasca R; Torelli G
Leuk Res; 2008 Apr; 32(4):593-7. PubMed ID: 17928052
[TBL] [Abstract][Full Text] [Related]
22. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
[TBL] [Abstract][Full Text] [Related]
23. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
[TBL] [Abstract][Full Text] [Related]
24. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
[TBL] [Abstract][Full Text] [Related]
25. ZO-1 expression shows prognostic value in chronic B cell leukemia.
Nesmiyanov PP; Tolkachev BE; Strygin AV
Immunobiology; 2016 Jan; 221(1):6-11. PubMed ID: 26306999
[TBL] [Abstract][Full Text] [Related]
26. Analysis of CD38 and ZAP70 mRNA expression among cytogenetic subgroups of Iranian chronic-lymphocytic-leukemia patients.
Teimori H; Akbari MT; Hamid M; Forouzandeh M; Bibordi E
Genet Mol Res; 2011 Oct; 10(4):2415-23. PubMed ID: 22002134
[TBL] [Abstract][Full Text] [Related]
27. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia.
Chantepie SP; Vaur D; Grunau C; Salaün V; Briand M; Parienti JJ; Heutte N; Cheze S; Roussel M; Gauduchon P; Leporrier M; Krieger S
Leuk Res; 2010 Jun; 34(6):800-8. PubMed ID: 19944462
[TBL] [Abstract][Full Text] [Related]
28. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
29. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
[TBL] [Abstract][Full Text] [Related]
30. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
[TBL] [Abstract][Full Text] [Related]
31. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
32. Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.
Röth A; de Beer D; Nückel H; Sellmann L; Dührsen U; Dürig J; Baerlocher GM
Br J Haematol; 2008 Nov; 143(3):383-6. PubMed ID: 18759763
[TBL] [Abstract][Full Text] [Related]
33. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
34. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
Molica S; Cutrona G; Vitelli G; Mirabelli R; Molica M; Digiesi G; Ribatti D; Ferrarini M; Vacca A
Leuk Res; 2007 Nov; 31(11):1575-8. PubMed ID: 17485110
[TBL] [Abstract][Full Text] [Related]
35. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.
Rossi D; Cerri M; Capello D; Deambrogi C; Rossi FM; Zucchetto A; De Paoli L; Cresta S; Rasi S; Spina V; Franceschetti S; Lunghi M; Vendramin C; Bomben R; Ramponi A; Monga G; Conconi A; Magnani C; Gattei V; Gaidano G
Br J Haematol; 2008 Jun; 142(2):202-15. PubMed ID: 18492108
[TBL] [Abstract][Full Text] [Related]
36. Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.
Pearce L; Morgan L; Lin TT; Hewamana S; Matthews RJ; Deaglio S; Rowntree C; Fegan C; Pepper C; Brennan P
Haematologica; 2010 Mar; 95(3):514-7. PubMed ID: 20207849
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.
Carreras J; Villamor N; Colomo L; Moreno C; Ramón y Cajal S; Crespo M; Tort F; Bosch F; López-Guillermo A; Colomer D; Montserrat E; Campo E
J Pathol; 2005 Mar; 205(4):507-13. PubMed ID: 15685592
[TBL] [Abstract][Full Text] [Related]
39. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.
Morabito F; Cutrona G; Gentile M; Matis S; Todoerti K; Colombo M; Sonaglio C; Fabris S; Reverberi D; Megna M; Spriano M; Lucia E; Rossi E; Callea V; Mazzone C; Festini G; Zupo S; Molica S; Neri A; Ferrarini M
Br J Haematol; 2009 Jun; 146(1):44-53. PubMed ID: 19438486
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients.
Gogia A; Sharma A; Raina V; Kumar L; Gupta R; Kumar R
Indian J Cancer; 2013; 50(4):333-6. PubMed ID: 24369212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]